Two advanced treatments for skin improvement with entirely different biological goals
Cosmelan and Sculptra both belong to the professional, advanced end of aesthetic medicine, yet despite being offered by clinics working with skin rejuvenation, they are fundamentally developed for entirely different indications and skin conditions. One addresses pigmentation and skin tone; the other targets volume, firmness, and structure.
This makes the comparison between them both interesting and important, particularly for clinics that need to guide patients with complex skin concerns and clear aesthetic goals.
How does Cosmelan work?
Cosmelan is a medical depigmentation system globally recognised as one of the most effective treatments for melasma, sun damage, hormonal pigmentation, and post-inflammatory pigment spots. Its strength lies in the fact that it not only reduces existing pigmentation but also regulates the underlying process of pigment formation, by inhibiting the activity of tyrosinase — the enzyme that controls melanin production.
Treatment begins at the clinic, where an active mask is applied, and continues with a structured home programme lasting several months to achieve long-term stabilisation of melanocyte activity. The result is skin with a more even tone, less visible spots, and markedly improved clarity — and above all, a reduced tendency for the pigmentation to return.
How does Sculptra work?
Sculptra occupies an entirely different domain within aesthetic medicine.
It is an injectable treatment based on poly-L-lactic acid (PLLA), a biocompatible substance that stimulates fibroblasts to produce new collagen. Rather than filling specific lines or creating immediate volume, Sculptra progressively builds up the skin’s structure from within. This makes it suitable for patients who have lost volume in the cheeks, temples, or jawline, or whose skin has become thin, lax, or lost its natural elasticity. The effect develops over months as new collagen is formed, and results are considerably more durable than those of traditional fillers — often lasting up to two years or beyond.
When comparing the two, their different areas of focus become clear. Cosmelan is a dedicated pigment treatment whose aim is to normalise melanogenesis and reduce hyperpigmentation. Sculptra is a structural treatment that works at the foundation of the skin by rebuilding collagen. These treatments do not overlap in purpose, but they complement each other well within comprehensive treatment plans where both skin tone and skin quality need to be improved.
Which treatment is most suitable?
Cosmelan is recommended for patients dealing with pigmentation spots regardless of skin type, but particularly those with melasma or pigmentation that returns despite repeated simpler treatments. For these patients, a treatment is needed that addresses melanin at depth, since the problem does not lie solely in the skin’s surface. Cosmelan is one of the few protocols capable of delivering long-lasting results when the home programme is followed correctly.
Sculptra is best suited to patients with visible volume loss or early skin laxity that affects the face’s contours and proportions. It also suits patients who want a natural result without direct volume augmentation, and who have the patience to allow the effect to build over several months. The treatment is an attractive option for those who wish to avoid filler aesthetics and instead prefer a more subtle rejuvenation.
Cosmelan involves a more noticeable treatment phase in which the skin, during the first weeks, may feel red, dry, and mildly flaky — which is part of the active depigmentation process. The patient must be motivated to follow the home programme carefully, as a significant part of the treatment takes place at home over several months. Sculptra, in contrast, has very limited downtime. After injection, mild swelling and small nodules may occur, managed by massaging the area several times a day for the first five days. Thereafter, the skin typically returns to normal, and the collagen stimulation process continues without any noticeable impact on the patient’s daily life.
Cosmelan produces gradual but dramatic improvements in skin tone and pigmentation. After six to twelve weeks, a clear lightening of melasma and sun spots is visible, and over further time the skin’s clarity and evenness continue to improve. Results are long-lasting as long as the patient uses sun protection and follows the aftercare programme. Sculptra delivers structural improvements that develop over several months. As new collagen is built up, the skin becomes fuller, more elastic, and more youthful in its structure. The effect is subtle but distinct and very natural — typically lasting two years or more.
For clinics, the key conclusion is that Cosmelan and Sculptra are not competitors, but two entirely different tools within a broader treatment arsenal. The patient who needs a more even skin tone should be directed towards Cosmelan, while the patient who needs structural rebuilding and volume should be recommended Sculptra. In advanced treatment plans, the two can advantageously be combined over time: Cosmelan first to create a clearer, more consistent skin tone, and Sculptra thereafter to restore volume, firmness, and a younger, more harmonious facial structure.
Frequently Asked Questions
Cosmelan is a medical depigmentation system designed to treat melasma, sun damage, and hormonal pigmentation by inhibiting tyrosinase and regulating melanin production. Sculptra is a biostimulatory injectable based on poly-L-lactic acid (PLLA) that restores volume and rebuilds structure by stimulating new collagen formation. Cosmelan addresses skin tone; Sculptra addresses skin volume and firmness.
Cosmelan is recommended for patients with melasma, post-inflammatory hyperpigmentation, sun damage, or pigmentation that has returned despite simpler treatments. Sculptra is the right choice for patients with visible volume loss in the cheeks, temples, or jawline, or with early skin laxity affecting facial contours. The two treatments serve entirely different indications.
Yes. They are not competitors but complementary tools. A typical sequenced approach is to begin with Cosmelan to establish a more even, clearer skin tone, and then introduce Sculptra to rebuild volume, firmness, and facial structure. This combination produces both improved skin quality and structural rejuvenation.
Cosmelan has a more noticeable recovery phase: the skin can feel red, dry, and mildly flaky during the first two to three weeks, and patients must follow a structured home programme over several months. Sculptra has very limited downtime, with mild swelling and occasional small nodules that respond to the recommended 5-5-5 massage routine after injection.
Cosmelan delivers long-lasting pigment improvement provided the patient uses daily sun protection and follows the aftercare programme. Sculptra produces structural results that typically last two years or longer, as the newly formed collagen continues to support the treated areas.
